BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 98 filers reported holding BIOSCRIP INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $32,067,000 | +34.4% | 12,333,605 | +3.4% | 41.89% | +38.9% |
| Q1 2019 | $23,867,000 | -48.0% | 11,933,605 | -7.2% | 30.16% | -9.1% |
| Q4 2018 | $45,895,000 | +2.3% | 12,855,619 | -11.2% | 33.17% | +59.9% |
| Q3 2018 | $44,873,000 | +6.2% | 14,475,087 | +0.3% | 20.74% | -17.7% |
| Q2 2018 | $42,266,000 | +17.3% | 14,425,087 | -1.5% | 25.21% | +16.0% |
| Q1 2018 | $36,042,000 | -12.8% | 14,651,292 | +3.1% | 21.73% | -18.0% |
| Q4 2017 | $41,345,000 | +26.7% | 14,207,992 | +19.7% | 26.50% | +41.4% |
| Q3 2017 | $32,643,000 | +0.1% | 11,870,322 | -1.1% | 18.74% | -14.7% |
| Q2 2017 | $32,595,000 | +59.7% | 12,005,453 | 0.0% | 21.96% | +101.1% |
| Q1 2017 | $20,409,000 | – | 12,005,453 | – | 10.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |